orchard
therapeutics
host
virtual
r
investor
event
friday
november
boston
london
globe
newswire
orchard
therapeutics
nasdaq
ortx
global
gene
therapy
leader
today
announced
company
webcast
virtual
r
event
new
horizons
gene
therapy
friday
november
et
members
orchard
management
team
gene
therapy
expert
present
overview
company
development
hematopoietic
stem
cell
hsc
gene
therapy
genetic
subsets
frontotemporal
dementia
ftd
crohn
disease
well
latest
innovations
lentiviral
vector
drug
product
manufacturing
presentations
given
bobby
gaspar
chief
executive
officer
alessandra
biffi
professor
chair
pediatric
hematology
oncology
stem
cell
transplant
division
padua
university
faculty
pediatrics
harvard
medical
school
gene
therapy
program
dana
farber
boston
children
cancer
blood
disorders
center
piv
sagoo
director
gene
cell
therapy
research
ran
zheng
chief
technical
officer
frank
thomas
president
chief
operating
officer
live
webcast
presentation
available
news
events
investors
media
section
company
website
replay
webcast
archived
orchard
website
following
presentation
would
like
rsvp
please
contact
orchard
orchard
orchard
therapeutics
global
gene
therapy
leader
dedicated
transforming
lives
people
affected
rare
diseases
development
innovative
potentially
curative
gene
therapies
ex
vivo
autologous
gene
therapy
approach
harnesses
power
genetically
modified
blood
stem
cells
seeks
correct
underlying
cause
disease
single
administration
orchard
acquired
gsk
rare
disease
gene
therapy
portfolio
originated
pioneering
collaboration
gsk
san
raffaele
telethon
institute
gene
therapy
milan
italy
orchard
one
deepest
advanced
gene
therapy
product
candidate
pipelines
industry
spanning
multiple
therapeutic
areas
disease
burden
children
families
caregivers
immense
current
treatment
options
limited
exist
orchard
global
headquarters
london
headquarters
boston
information
please
visit
follow
us
twitter
linkedin
availability
information
orchard
investors
others
note
orchard
communicates
investors
public
using
company
website
investor
relations
website
social
media
twitter
linkedin
including
limited
investor
presentations
investor
fact
sheets
securities
exchange
commission
filings
press
releases
public
conference
calls
webcasts
information
orchard
posts
channels
websites
could
deemed
material
information
result
orchard
encourages
investors
media
others
interested
orchard
review
information
posted
channels
including
investor
relations
website
regular
basis
list
channels
may
updated
time
time
orchard
investor
relations
website
may
include
additional
social
media
channels
contents
orchard
website
channels
website
may
accessed
website
channels
shall
deemed
incorporated
reference
filing
securities
act
contacts
investors
renee
leck
director
investor
relations
